Multigene kinase network, kidney transport, and salt in essential hypertension

Kidney International

Volumn 77, Issue 12, 2012, Pages 1063-1069

  Welling, Paul A ^a   Chang, Yen Pei C ^a   Delpire, Eric ^b   Wade, James B ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

aldosterone; angiotensin; hypertension; NaCl cotransporter; potassium channels

Indexed keywords

ALANINE; ALDOSTERONE; LYSINE; MINERALOCORTICOID; POTASSIUM; PROLINE; PROTEIN KINASE WNK1; PROTEIN KINASE WNK4; SODIUM; SODIUM CHLORIDE; SODIUM CHLORIDE COTRANSPORTER; PHOSPHOTRANSFERASE; PROTEIN SERINE THREONINE KINASE; STK39 PROTEIN, HUMAN;

ALDOSTERONE BLOOD LEVEL; BLOOD PRESSURE REGULATION; CHRONIC KIDNEY DISEASE; ESSENTIAL HYPERTENSION; GENE MUTATION; GENETIC VARIABILITY; HUMAN; KIDNEY DISTAL TUBULE; KIDNEY TUBULE ABSORPTION; NONHUMAN; POTASSIUM EXCRETION; POTASSIUM INTAKE; POTASSIUM TRANSPORT; PRIORITY JOURNAL; REVIEW; SALT INTAKE; SODIUM ABSORPTION; SODIUM EXCRETION; SODIUM INTAKE; SODIUM RETENTION; SODIUM TRANSPORT; GENETICS; HYPERTENSION; KIDNEY; METABOLISM; TRANSPORT AT THE CELLULAR LEVEL;

BIOLOGICAL TRANSPORT; HUMANS; HYPERTENSION; KIDNEY; PHOSPHOTRANSFERASES; PROTEIN-SERINE-THREONINE KINASES; SODIUM CHLORIDE, DIETARY;

EID: 77955359609     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2010.103     Document Type: Short Survey

References (63)

1. Wang Y, O'Connell JR, McArdle PF et al. Whole-genome association study identifies STK39 as a hypertension susceptibility gene. Proc Natl Acad Sci USA 2009; 106: 226-231.
2. Guyton AC. Blood pressure control-special role of the kidneys and body fluids. Science 1991; 252: 1813-1816. (Pubitemid 21917099)
3. Lifton RP, Gharavi AG, Geller DS. Molecular mechanisms of human hypertension. Cell 2001; 104: 545-556. (Pubitemid 32201949)
4. Simon DB, Nelson-Williams C, Bia MJ et al. Gitelman's variant of Bartter's syndrome, inherited hypokalaemic alkalosis, is caused by mutations in thethiazide-sensitive Na-Cl cotransporter. Nat Genet 1996; 12: 24-30. (Pubitemid 26011315)
5. Wilson FH, Disse-Nicodeme S, Choate KA et al. Human hypertension caused by mutations in WNK kinases. Science 2001; 293: 1107-1112. (Pubitemid 32758085)
6. Ji W, Foo JN, O'Roak BJ et al. Rare independent mutations in renal salt handling genes contributeto blood pressure variation. Nat Genet 2008; 40: 592-599. (Pubitemid 351601207)
7. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002; 288: 2981-2997.
8. Sacks FM, Svetkey LP, Vollmer WM et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med 2001; 344: 3-10. (Pubitemid 32064838)
9. Obarzanek E, Proschan MA, Vollmer WM et al. Individual blood pressure responses to changes in salt intake: results from the DASH-Sodium trial. Hypertension 2003; 42: 459-467. (Pubitemid 37237339)
10. Appel LJ, Brands MW, Daniels SR et al. Dietary approaches to prevent and treat hypertension: a scientific statement from the American Heart Association. Hypertension 2006; 47: 296-308. (Pubitemid 43189776)
11. Lichtenstein AH, Appel LJ, Brands M et al. Summary of American Heart Association Diet and Lifestyle Recommendations revision 2006. Arterioscler Thromb Vasc Biol 2006; 26: 2186-2191. (Pubitemid 44465710)
12. Subramanya AR, Yang CL, McCormick JA et al. WNK kinases regulate sodium chloride and potassium transport by the aldosterone-sensitive distal nephron. Kidney Int 2006; 70: 630-634. (Pubitemid 44215335)
13. Welling PA, Ho K. A comprehensive guideto the ROMK potassium channel: form and function in health and disease. Am J Physiol Renal Physiol 2009; 297: F849-F863.
14. Reilly RF, Ellison DH. Mammalian distal tubule: physiology, pathophysiology, and molecular anatomy. Physiol Rev 2000; 80: 277-313. (Pubitemid 30060566)
15. McCormick JA, Yang CL, Ellison DH. WNK kinases and renal sodium transport in health and disease: an integrated view. Hypertension 2008; 51: 588-596.
16. Richardson C, Alessi DR. The regulation of salt transport and blood pressure by the WNK-SPAK/OSR1 signalling pathway. J Cell Sci 2008; 121: 3293-3304.
17. Wilson FH, Kahle KT, Sabath E et al. Molecular pathogenesis of inherited hypertension with hyperkalemia: the Na-Cl cotransporter is inhibited by wild-type but not mutant WNK4. Proc Natl Acad Sci USA 2003; 100: 680-684. (Pubitemid 36126112)
18. Yang CL, Angell J, Mitchell R et al. WNK kinases regulatethiazide- sensitive Na-Cl cotransport. J Clin Invest 2003; 111: 1039-1045. (Pubitemid 36397480)
19. Yang SS, Morimoto T, Rai T et al. Molecular pathogenesis of pseudohypoaldosteronism type II: generation and analysis of a Wnk4(D561A/+) knockin mouse model. Cell Metab 2007; 5: 331-344. (Pubitemid 46679517)
20. Huang CL, Yang SS, Lin SH. Mechanism of regulation of renal ion transport by WNK kinases. Curr Opin Nephrol Hypertens 2008; 17: 519-525.
21. Kahle KT, Wilson FH, Leng Q et al. WNK4 regulates the balance between renal NaCl reabsorption and K+ secretion. Nat Genet 2003; 35: 372-376. (Pubitemid 37486922)
22. Sandberg MB, Riquier AD, Pihakaski-Maunsbach K et al. ANG II provokes acutetrafficking of distal tubule Na+-Cl(-) cotransporter to apical membrane. Am J Physiol Renal Physiol 2007; 293: F662-F669. (Pubitemid 47403333)
23. Wei Y, Zavilowitz B, Satlin LM et al. Angiotensin II inhibits the ROMK-like small conductance K channel in renal cortical collecting duct during dietary potassium restriction. J Biol Chem 2007; 282: 6455-6462. (Pubitemid 47100885)
24. San Cristobal P, Pacheco-Alvarez D, Richardson C et al. Angiotensin II signaling increases activity of the renal Na-Cl cotransporter through a WNK4-SPAK-dependent pathway. Proc Natl Acad Sci USA 2009; 106: 4384-4389.
25. Moriguchi T, Urushiyama S, Hisamoto N et al. WNK1 regulates phosphorylation of cation-chloride-coupled cotransporters via the STE20-related kinases, SPAK and OSR1. J Biol Chem 2005; 280: 42685-42693. (Pubitemid 43049227)
26. Zagorska A, Pozo-Guisado E, Boudeau J et al. Regulation of activity and localization of the WNK1 protein kinase by hyperosmotic stress. J Cell Biol 2007; 176: 89-100. (Pubitemid 46041683)
27. Vitari AC, Deak M, Collins BJ et al. WNK1, the kinase mutated in an inherited high-blood-pressure syndrome, is a novel PKB (protein kinase B)/Akt substrate. Biochem J 2004; 378: 257-268. (Pubitemid 38299565)
28. Xu BE, Stippec S, Lazrak A et al. WNK1 activates SGK1 by a phosphatidylinositol 3-kinase-dependent and non-catalytic mechanism. J Biol Chem 2005; 280: 34218-34223. (Pubitemid 41443147)
29. Song J, Hu X, Riazi S et al. Regulation of blood pressure, the epithelial sodium channel (ENaC), and other key renal sodium transporters by chronic insulin infusion in rats. Am J Physiol Renal Physiol 2006; 290: F1055-F1064. (Pubitemid 43724904)
30. Ring AM, Leng Q, Rinehart J et al. An SGK1 site in WNK4 regulates Na+ channel and K+ channel activity and has implications for aldosterone signaling and K+ homeostasis. Proc Natl Acad Sci USA 2007; 104: 4025-4029. (Pubitemid 47181572)
31. Yang CL, Zhu X, Ellison DH. Thethiazide-sensitive Na-Cl cotransporter is regulated by a WNK kinase signaling complex. J Clin Invest 2007; 117: 3403-3411. (Pubitemid 350096996)
32. Rozansky DJ, Cornwall T, Subramanya AR et al. Aldosterone mediates activation of thethiazide-sensitive Na-Cl cotransporter through an SGK1 and WNK4 signaling pathway. J Clin Invest 2009; 119: 2601-2612.
33. Yue P, Lin DH, Pan CY et al. Src family protein tyrosine kinase (PTK) modulates the effect of SGK1 and WNK4 on ROMK channels. Proc Natl Acad Sci USA 2009; 106: 15061-15066.
34. Yang CL, Zhu X, Wang Z et al. Mechanisms of WNK1 and WNK4 interaction in the regulation of thiazide-sensitive NaCl cotransport. J Clin Invest 2005; 115: 1379-1387. (Pubitemid 40629058)
35. Rinehart J, Kahle KT, de Los HP et al. WNK3 kinase is a positive regulator of NKCC2 and NCC, renal cation-Cl-cotransporters required for normal blood pressure homeostasis. Proc Natl Acad Sci USA 2005; 102: 16777-16782. (Pubitemid 41688853)
36. Glover M, Zuber AM, O'Shaughnessy KM. Renal and brain isoforms of WNK3 have opposite effects on NCCT expression. J Am Soc Nephrol 2009; 20: 1314-1322.
37. Vallon V, Schroth J, Lang F et al. Expression and phosphorylation of the Na-Cl-cotransporter NCC in vivo is regulated by dietary salt, potassium and SGK1. Am J Physiol Renal Physiol 2009; 297: F704-F712.
38. Vitari AC, Deak M, Morrice NA et al. The WNK1 and WNK4 protein kinases that are mutated in Gordon's hypertension syndrome phosphorylate and activate SPAK and OSR1 protein kinases. Biochem J 2005; 391: 17-24. (Pubitemid 41445471)
39. Ohta A, Rai T, Yui N et al. Targeted disruption of the Wnk4 gene decreases phosphorylation of Na-Cl cotransporter, increases Na excretion, and lowers blood pressure. Hum Mol Genet 2009; 18: 3978-3986.
40. Subramanya AR, Yang CL, Zhu X et al. Dominant-negative regulation of WNK1 by its kidney-specific kinase-defective isoform. Am J Physiol Renal Physiol 2006; 290: F619-F624. (Pubitemid 43724963)
41. San Cristobal P, Ponce-Coria J, Vazquez N et al. WNK3 and WNK4 aminoterminal domain defines their effect on the renal Na+-Clcotransporter. Am J Physiol Renal Physiol 2008; 295: F1199-F1206.
42. Lalioti MD, Zhang J, Volkman HM et al. Wnk4 controls blood pressure and potassium homeostasis via regulation of mass and activity of the distal convoluted tubule. Nat Genet 2006; 38: 1124-1132. (Pubitemid 44470357)
43. Subramanya AR, Liu J, Ellison DH et al. WNK4 diverts thethiazide- sensitive NaCl cotransporter to the lysosome and stimulates AP-3 interaction. J Biol Chem 2009; 284: 18471-18480.
44. Sansom SC, Welling PA. Two channels for one job. Kidney Int 2007; 72: 529-530. (Pubitemid 47312802)
45. Frindt G, Palmer LG. K+ secretion in the rat kidney: Na+ channeldependent and-independent mechanisms. Am J Physiol Renal Physiol 2009; 297: F389-F396.
46. O'Reilly M, Marshall E, Speirs HJ et al. WNK1, a gene within a novel blood pressure control pathway, tissue-specifically generates radically different isoforms with and without a kinase domain. J Am Soc Nephrol 2003; 14: 2447-2456. (Pubitemid 37169330)
47. Delaloy C, Lu J, Houot AM et al. Multiple promoters in the WNK1 gene: one controls expression of a kidney-specific kinase-defective isoform. Mol Cell Biol 2003; 23: 9208-9221. (Pubitemid 37499808)
48. Lazrak A, Liu Z, Huang CL. Antagonistic regulation of ROMK by long and kidney-specific WNK1 isoforms. Proc Natl Acad Sci USA 2006; 103: 1615-1620. (Pubitemid 43191213)
49. Wade JB, Fang L, Liu J et al. WNK1 kinase isoform switch regulates renal potassium excretion. Proc Natl Acad Sci USA 2006; 103: 8558-8563. (Pubitemid 43838494)
50. Liu Z, Wang HR, Huang CL. Regulation of ROMK channel and K+ homeostasis by kidney-specific WNK1 kinase. J Biol Chem 2009; 284: 12198-12206.
51. Yoo D, Kim BY, Campo C et al. Cell surface expression of the ROMK (Kir 1.1) channel is regulated by the aldosterone-induced kinase, SGK-1, and protein kinase A. J Biol Chem 2003; 278: 23066-23075. (Pubitemid 36830372)
52. Stokes JB. Consequences of potassium recycling in the renal medulla. Effects of ion transport by the medullary thick ascending limb of Henle's loop. J Clin Invest 1982; 70: 219-229. (Pubitemid 12042620)
53. Fang L, Garuti R, Kim BY et al. The ARH adaptor protein regulates endocytosis of the ROMK potassium secretory channel in mouse kidney. J Clin Invest 2009; 119: 3278-3289.
54. Piechotta K, Lu J, Delpire E. Cation chloride cotransporters interact with the stress-related kinases Ste20-related proline-alanine-rich kinase (SPAK) and oxidative stress response 1 (OSR1). J Biol Chem 2002; 277: 50812-50819. (Pubitemid 36042246)
55. Delpire E, Gagnon KB. SPAK and OSR1, key kinases involved in the regulation of chloridetransport. Acta Physiol (Oxf) 2006; 187: 103-113. (Pubitemid 43828768)
56. Gagnon KB, England R, Delpire E. Characterization of SPAK and OSR1, regulatory kinases of the Na-K-2Cl cotransporter. Mol Cell Biol 2006; 26: 689-698. (Pubitemid 43089779)
57. Piechotta K, Garbarini N, England R et al. Characterization of the interaction of the stress kinase SPAK with the Na+-K+-2Clcotransporter in the nervous system: evidence for a scaffolding role of the kinase. J Biol Chem 2003; 278: 52848-52856. (Pubitemid 38035884)
58. Geng Y, Hoke A, Delpire E. The Ste20 kinases Ste20-related prolinealanine-rich kinase and oxidative-stress response 1 regulate NKCC1 function in sensory neurons. J Biol Chem 2009; 284: 14020-14028.
59. Li Y, Hu J, Vita R et al. SPAK kinase is a substrate and target of PKCtheta in T-cell receptor-induced AP-1 activation pathway. EMBO J 2004; 23: 1112-1122. (Pubitemid 38436875)
60. Smith L, Smallwood N, Altman A et al. PKCdelta acts upstream of SPAK in the activation of NKCC1 by hyperosmotic stress in human airway epithelial cells. J Biol Chem 2008; 283: 22147-22156.
61. Sober S, Org E, Kepp K et al. Targeting 160 candidate genes for blood pressure regulation with a genome-wide genotyping array. PLoS One 2009; 4: e6034.
62. Newton-Cheh C, Johnson T, Gateva V et al. Genome-wide association study identifies eight loci associated with blood pressure. Nat Genet 2009; 41: 666-676.
63. Levy D, Ehret GB, Rice K et al. Genome-wide association study of blood pressure and hypertension. Nat Genet 2009; 41: 677-687.